Cancer cells create a unique microenvironment in vivo which enables migration to distant organs. To better understand the tumor microenvironment, special tools and devices are required to monitor the interactions between different cell types and the effects of particular chemical gradients. This study presents the design and optimization of a new, versatile chemotaxis device called the NANIVID (NANo IntraVital Device). The device is fabricated using BioMEMS techniques and consists of etched and bonded Pyrex substrates, a soluble factor reservoir, fluorescent tracking beads and a microelectrode array for cell quantification. The reservoir contains a customized hydrogel blend loaded with EGF which diffuses out of the hydrogel to create a chemotactic gradient. This reservoir sustains a steady release of growth factor into the surrounding environment for many hours and establishes a concentration gradient that attracts specific cells to the device. In addition to a cell collection tool, the NANIVID can be modified to act as a delivery vehicle for the local generation of alternate soluble factor gradients to initiate controlled changes to the microenvironment such as hypoxia, ECM stiffness and etc. The focus of this study is to design and optimize the new device for wide ranging studies of breast cancer cell dynamics in vitro and ultimately, implantation for in vivo work.
INTRODUCTION
Cell migration is critical for the survival, development and maintenance of multicellular organisms [1] [2] [3] . External stimuli are required for guiding normal cellular migration [4] [5] [6] but defective cells can respond to these signals in unintended ways, leading to tumor formation [7] . Tumors consist of various types of cells, chemokines and cytokines which create a microenvironment that is much different than that of normal tissue. A tumor is a dynamic system, which can evolve and adapt its microenvironment to facilitate angiogenesis and metastasis [8] [9] [10] . When a tumor reaches a large enough size, the inner regions may not have access to sufficient oxygen and a hypoxic environment is produced [11] . Studies have shown that hypoxia plays an important role in tumor progression, affecting the metastatic spread of cancer and the selection for cells with a more aggressive phenotype [12, 13] . Deeper understanding of the processes involved in tumor progression, such as chemotaxis and hypoxia, requires robust technologies that are capable of changing the cellular microenvironment both in vitro and in vivo.
BioMEMS is an emerging technology which has the potential to develop a variety of assays for both 2D and 3D cellular chemotaxis studies. Conventional assays including Boyden's [14] , Dunn's chamber [15] and micropipet based [16] assays are being used to study this field but each has limitations. Progress has been made to study these biological processes with modified [17] [18] [19] or new chemotaxis assays [20, 21] . Ainla [22] modified the traditional micropipet assay by utilizing a microfluidic approach which enabled improved spatial control over the concentration gradient. Micropipet assays have their own inherent limitations, such as requiring the use of bulk equipment and expertise to position the tip, and a low throughput due to only studying a single cell at a time. In most microfluidic devices, an external tubing, pumping system is required and cellular cultivation must occur inside the device which prevents usage in most in vivo application [23] , [24] .
Cheng [25] used agarose hydrogel as a structural material to develop a microfluidic device consisting of parallel channels which created a chemical gradient by diffusion through a hydrogel membrane. Varieties of 3D assays [26] [27] [28] were also developed to mimic the in vivo microenvironment. Most of these assays are created for in vitro characterization studies and there are significant difficulties in transitioing them to in vivo applications.
The only known chemotaxis assay that can be easily used both in vitro and in vivo is a needle based assay [29] . In this assay, a stainless steel needle (100µm inner diameter) loaded with matrigel and growth factor is used to create a physiological relevant gradient to attract cells. We propose a novel research tool called the NANIVID or NANo Intra VItal Device [30] that is manufactured using microfabrication and BioMEMS techniques. The NANIVID is made of biocompatible, optically transparent materials and contains a customized hydrogel that was tested on both human and rat mammary gland cancer cells. The devices can be loaded with a chemoattractant of interest, such as epidermal growth factor (EGF), or agents to induce changes in the tumor microenvironment, such as cobalt chloride (CoCl 2 ) which can artificially induce hypoxia [31, 32] . The hydrogel material is capable of releasing EGF or CoCl 2 into the environment in a controlled manner through a single outlet in the device. The device can be used to collect cells through active migration into the device towards the chemoattractant gradient. Also, the device can be used as a disseminator of chemical agents to manipulate the microenvironment as desired. To monitor the interior of the device, an electrode system was designed to detect the presence of cells based on a change in impedance. The fabrication process and materials used in the NANIVID were selected so that it can be used easily in both existing tissue culture techniques (2D, 3D) and in animal models.
MATERIALS AND METHODS

Device Fabrication and Loading
NANIVID were fabricated using bioMEMS techniques. Briefly, optically transparent, biocompatable substrates with the etched features were diced, cleaned and sealed from the top using a glass bonded PDMS film [30, 33, 34] . Both the etched substrate and the PDMS surface were treated with oxygen plasma to activate their surfaces. The hydrogel containing EGF was cured in the back end of device, and the two pieces were bonded together. Polyethylene glycol diacrylate (PEGDA) blended with methoxy polyethylene glycol monoacrylate (PEGMA) was used as the hydrogel system in the device, with final concentrations of PEGDA and PEGMA of 20% and 10%, respectively [30] . The devices used to artificially generate a hypoxia environment were loaded with hydrogel containing cobalt chloride (CoCl 2 ).
Device Release Dynamics
The NANIVID were loaded with Rhodamine EGF (R-EGF) mixed in a hydrogel blend and bonded as described above.
In the bulk release experiments, multiple devices were placed in each well of a 12-well plate. The devices were hydrated in starvation media (L15 + 0.8% BSA), degassed briefly by low vacuum treatment, and inspected using an optical microscope. Samples were then collected from each well at various time intervals and stored at -20 o C until measurement.
The collected samples were transferred into 96-well plates along with standard solutions and analyzed using a microplate fluorometer. The fluorescence intensity was then converted into nM concentration using a standard curve. To quantify the chemical gradient released from the device, R-EGF loaded devices were hydrated in a petri dish with starvation media and then transferred to a MatTek glass bottom dish. A thin layer of mineral oil (Sigma-Aldrich) was cast on the top of the media to reduce evaporation and the device was imaged using a fluorescent microscope. Time lapse experiments were performed and the images were analyzed using ImageJ software (NIH). The fluorescence intensity was measured in front of the device and converted into an R-EGF concentration using a standard curve. 
Cell Culture in 2D and 3D
Cell Migration Assay (2D)
MTLn3 Mena Inv cells were starved in L15 media including 0.8% BSA (Sigma-Aldrich) for 2.5hr before the migration assay. Devices loaded with various concentrations of EGF (i.e. 0µM, 4.5µM, 5µM, 6µM, 7µM and 7.5µM) were hydrated in starvation media and then transferred to the dishes that contained the starved cells. Images were collected at different time intervals under a phase contrast microscope as shown in Figure 1A . The collected images were analyzed using ImageJ software (NIH). The centroid of each cell was tracked using the ROI Tracker plugin for ImageJ. The cell tracking data was analyzed and different parameters were calculated including vector plots, turning frequency, directionality, chemotaxis index and effective chemotaxis index.
Cell Invasion in 3D
MDA-MB-231 cells expressing GFP were starved overnight in L15 media supplemented with 0.8% BSA and 0.5% FBS before the invasion assay. Devices loaded with hydrogel containing various EGF concentrations (0.1µM, 0.5µM, 1µM, 2µM) were hydrated in matrigel and degassed by low vacuum treatment. These concentrations were approximately half of those which were used in the 2D migration assay. The hydrated devices were examined under a microscope to assure that no air bubbles were trapped in the device chamber. Devices were then inserted into the matrigel matrix containing the starved MDA-MB-231 cells. The region near the device opening was imaged at different time intervals using a Leica confocal microscope. Z-stacks of this region were analyzed using ImageJ software.
Mimicking Hypoxia
CoCl 2 was used as a hypoxia inducing agent [31] on MTLn3-HIF-tagRFP cells. The cells were cultured as mentioned above and exposed to CoCl 2 either by direct addition to the media in the dish or from the release of CoCl 2 from devices loaded with CoCl 2 hydrogel. The fluorescent intensity measured from the cells due to RFP is related to the hypoxic conditions of the cells.
Electrode Fabrication and Electrodes Encapsulation
Interdigitated indium doped tin-oxide (ITO) electrodes and line gold electrodes were fabricated using photolithography [35] . The substrates were diced, cleaned and electrodes were covered with a PDMS top cover to mimic the device environment. The PDMS top cover was cast using an SU-8 mold. To fabricate the mold, a 100 mm silicon wafer was Piranha cleaned using a 3:1 mixture of H 2 SO 4 :H 2 O 2 . SU-8 2100 was spun on the wafer at 2000 rpm for 30 sec. The wafer was baked at 65°C for 10 min and 95°C for 45 min followed by exposure in an EVG 640 Contact Aligner. Post exposure bakes were performed at 65°C for 5 min and 95°C for 30 min, followed by development in SU-8
developer. The SU-8 mold surface was treated with OmniCoat (Sigma-Aldrich), and a PDMS solution was cast on the treated mold and was cured on the mold overnight at 60°C. The cured PDMS was removed from the mold as shown in Figure 1B and cut according to the device dimensions. The microelectrode substrate and the PDMS cover were treated with an oxygen plasma to activate their surfaces and bonded together.
Impedance Measurements
The bonded electrodes were sterilized overnight under UV light. After rinsing with buffer, the device was exposed to an oxygen plasma for 5 minutes to improve cell adhesion. Alpha-MEM was added to the wells and baseline impedance measurements were taken using the PARSTAT 2265 Potentiostat (Princeton Applied Research). The cells were suspended in media and added to a dish containing the device. The cells adhered to the electrodes and the impedance was measured with various cellular confluences. Impedance measurements were taken in the frequency range from 1 Hz to 1 MHz, at 10 mV rms with seven points per decade. The cells were imaged at each measurement over a period of 3 to 4 days. The cell impedance data was normalized to the media only impedance in order to determine the percentage change and to identify the ideal frequency range for these measurements. The impedance values at the optimal frequency were plotted against the corresponding coverage of cells on the electrodes. This cell coverage value was determined by analyzing the images in ImageJ software.
RESULTS AND DISCUSSION
Hydrogel systems used in this study were shown to release biologically active growth factors into the surrounding environment in a controlled fashion [30] . R-EGF is a fluorescent molecule (Ex/Em: 555/580 nm) and was used in a device release study to characterize the chemical gradient released from the device. Figure 2 shows the release of R-EGF in nM concentration from the device. Figure 2A represents the bulk release profile of R-EGF from the device with an insert showing the standard curve used to back calculate the R-EGF concentration from the fluorescent intensity. In these experiments, a slow and sustained release of the growth factor was observed. An average of more than 20% of the total growth factor in the hydrogel was released from the device over a period of 48 hours. The chemical diffusion gradient from the devices was also measured over the same duration as the cellular migration studies. Figure 2B shows the R-EGF gradient from the device outlet. The insert shows the design of the device with a line along which the R-EGF gradient was measured. A standard curve obtained by measuring the fluorescent intensity of serial dilutions of R-EGF under the microscope using the same conditions is also shown as an insert curve in Figure 2B . The hydrogel system used in the device releases growth factor due to passive diffusion after hydration, allowing the device to be self sufficient in releasing R-EGF into the environment. The gradient profile was flat in the first 20 minutes of the experiment and started to rise after 30 minutes, reaching a maximum value after 3 hours, as shown in Figure 2B . In another design of the device [30] , the amount of EGF released was even greater. The gradient slope of EGF release was also different between the various device designs (data not shown).
These devices were able to create a suitable chemical growth factor gradient to induce cancer cells (MTLn3 Mena Inv ) to migrate toward the device. The devices were loaded with a hydrogel blend containing various concentrations of EGF (i.e. 0 µM, 4.5 µM, 5 µM, 6 µM, 7 µM and 7.5 µM) and tested in vitro. The migration of the cells can be depicted by a vector plot which shows a vector for the movement of each cell. Vector plots are an ideal way to show the phenotypical behavior of these cells in the presence of chemoattractant gradients. Figure 3A is a representative image of cells tracked in the last frame of an experiment with the device located on the right hand side. Each white arrow shows the overall displacement (or vector) of the cell in that particular experiment while the colored lines depict the actual path of the cells. In the vector plots, all of the cell vectors were superimposed on one common origin to display the overall trend. In each of these experiments, the device is located on the right hand side. Figure 3B shows the control experiment (0µM EGF) in which the cells moved, as expected, in random directions. In the control experiment, the magnitude of each vector is small, indicating that these cells did not move far from their initial location due to random movement. When the EGF loaded devices were used, the growth factor gradient generated from the device outlet broke the symmetry of cellular movements. The cells begin to detect the gradient in their microenvironment and migrate toward the device as shown in Figure 3C -G. As the EGF loading was increased, the cell response becomes more pronounced with a maximum response observed at 7µM loading Figure 3F . The devices loaded with EGF concentrations below and above 7µM caused the cells to start losing directionality due to a weak EGF gradient and a higher receptor saturation rate, respectively. Figure: 2. Rhodamine-EGF release profile from the device. A) Bulk release of R-EGF in the dish from the device. The insert shows the standard curve that was used to back calculate R-EGF concentration in nM. B) R-EGF gradient profile along the device axis. The lower insert image shows the device design used in this study with a 400µm line drawn from the device opening, along which the gradient was measured. The upper insert graph shows the standard curve that was used to back calculate the R-EGF concentration in nM from the fluorescent intensity.
The turning frequency is a parameter to measure how often a cell changes its direction (angle) in various concentrations of growth factor gradients and can be measured in degrees per minute. The turning frequencies of the cells as shown in Figure 4A indicate that as the loading of EGF in the device was increased, from 0µM to 7µM, the turning frequency of the cells was reduced. The rate of turning was higher in the control experiments when there was no EGF in the device with an average value recorded of 41.43 degrees/minute. The minimum turning frequency observed was at 7µM with an average value of 24.38 degrees/minute. The cells with a higher turning frequency were less directional (measure how persistently cell is moving in one particular direction) and moved randomly for the duration of the experiment, with the majority of the cells ending up near the starting position. Figure 4B shows that in a 0 µM device, the lowest directionality was observed. The trend of the directionality curve should be the inverse of the turning frequency which was observed in these experiments. The highest directionality recorded was with 7 µM loaded devices with an average value 0.71 compared to the control devices with an average value of 0.23. Directionality was reduced in devices with EGF concentration greater than 7 µM, likely due to EGF receptor saturation. The average values of directionality were more than 0.6 for all the devices with EGF concentration of 5 µM or more.
The chemotaxis index plot in Figure 4C shows that MTLn3 Mena Inv cells respond to the artificially created growth factor gradient of the device. Chemotaxis is the directed movement of cells up the chemical concentration gradient. Various degrees of chemotaxis were observed with the devices loaded with different EGF concentrations. These devices showed an average chemotaxis index greater than 0.8 due to the production of a long lived EGF gradient, while the control devices had a chemotaxis index of nearly zero. The product of chemotaxis index and directionality yields the effective chemotaxis index, plotted in Figure 4D , which shows gradient biphasic response. A maximum of 0.649 effective chemotaxis index was measured in the device loaded with 7 µM EGF while the chemotaxis index was close to zero in the control experiments. This device design was able to attract the cells in the gradient of growth factor created by the device. When compared to other designs, this iteration allowed for less total EGF to be loaded into the device, as described elsewhere [30] . In preparation for in vivo studies, the design was modified and first tested in vitro in 3D culture. In the new version, the front of the device was diced at a 60 o angle, resulting in a sharp edge for easy device insertion. In addition, the outlet was moved to the side of the device to eliminate the possibility of clogging the device opening during insertion. Figure 5A shows the cross-section of the 3D cell invasion assay with the schematic of device inserted in the matrigel. Matrigel is a complex extracellular matrix secreted by Engelbreth-Holm-Swarm (EHS) mouse sarcoma cells. The cells were expressing GFP and to find the device opening under confocal microscope the opening of the device was marked with triangular feature containing fluorescent beads, not shown here. Figure 5B and C are the control (no EGF) and 2µM EGF devices, respectively. On first day, the devices were inserted into the matrigel containing starved cells, both in the control and EGF device the distribution of cells were similar around the device shown in the top panel of Figure 5B The NANIVID is under optimization to collect biological entities (i.e. cells) both in vitro and in vivo. In order to measure the real time status of the device, a non-invasive cellular sensing technique was used. An electrical sensing element will be added to the next generation of the device to serve that purpose. The change in electrical signal will be measured using patterned electrodes. The sensing element of the device is an ITO-based interdigitated electrode or line electrode system. MTLn3 Mena Inv cells were grown on the top electrodes both on open dies [35] and inside bonded devices. The open electrode characterization with material and designs is presented in somewhere else. Here the focus is on the bonded device response. A low density of cells (10 4 /mL) was seeded and the cells were allowed to proliferate for 3 days on the covered electrodes. The MTLn3 Mena Inv impedance was measured after connecting with a potentiostat. The devices with cells on the electrodes were kept sterile and the measurement methods were compatible with standard cell culture protocols. In this technique, connectors are outside the dishes that then can be connected to the potentiostat to facilitate impedance measurements. MTLn3 Mena Inv cells adhere to the ITO electrodes after 4 hours and grow normal as on a glass substrate for multiple days. In some devices, the cells seem to prefer the edges of the electrodes and elongate themselves as they sense the topography of the surface. Otherwise, the cells were mostly stretched uniformly over the fingers of the interdigitated electrodes and on the line electrodes.
The impedance spectra collected at the various times were normalized to the baseline measurements. This was done to identify the most sensitive frequencies. Figure 6 shows the normalized plot of the ITO interdigitated electrode. It can be seen that there is an increase in impedance in response to an increase in cell density. For the ITO interdigitated electrodes of 10µm fingers width and 5µm separation, the optimal frequency was determined to be 3 kHz, and the real impedance at 3 kHz vs. the percent area of the electrode covered was plotted as shown in Figure 6 . It is observed that in this electrode design system the initial 40% cell coverage raises the impedance quickly while after that the change plateaus. The impedance change for ITO interdigitated electrodes was plateaued at 80% confluence. The interdigitated electrode system was used because of the transparency requirement of the device but due to reduction in the size of the device, the available area of the electrode was limited. In the next design of the sensing element for the device, a gold electrode was used to reduce the resistance. The ITO material originally had high resistance which contributes to the higher resistance of the electrical measurement of NANIVID. In addition, instead of interdigitated electrodes, two line electrodes were designed. Figure 7 show the response of the gold line electrodes of width 10µm and separation 100µm and plotted as normalized impedance vs percent cell coverage. In this design of gold electrodes, the optimum frequency was determined to be 13 kHz. Plotted in Figure 7 is the impedance of gold line electrodes at 13 kHz vs cell coverage area. The maximum change observed was from 1 to 1.3 for 100% confluence where as in ITO interdigitated electrodes, the maximum change was from 1 to 1.05 for 100% confluence. In gold electrodes, small changes in the impedance were observed up to 20% coverage and between 20 to 80% coverage, the maximum impedance change was recorded. The impedance value was almost plateaued at ~80% or greater confluence. The line electrodes were not transparent but due to small feature size can be easily incorporated in the miniature version of the device and did not interfere with the imaging as shown in Figure 7 . One of the features of the device is to use it as a dispersant of specific chemical agents in the tumor microenvironment to manipulate and custom design the environment. CoCl 2 is an agent to create hypoxia both in vitro and in vivo. Devices were loaded with various concentrations of CoCl 2 and tested on MTLn3-HIF-tagRFP cells. These cells when exposed to 200 µM CoCl2 globally were under hypoxic condition and start to over express hypoxic inducing factor (HIF). The HIF was tagged with red fluorescent protein (RFP) and the fluorescent intensity measured from these cells was co-related with the expression of HIF. Figure 8 shows the results from the experiments conducted on these cells using devices loaded with hydrogel containing CoCl 2 (i.e. 2mM, 10mM and 20mM). The plot compares the results with the positive control. The devices were dehydrated in the media and placed in the dish having MTLn3-HIF-tagRFP cells and the fluorescent intensity of the cells was measured in front of the device. It was observed that as the CoCl 2 concentration was increased in the device, the fluorescent intensity was increased in the 4 and 8 hour time points while at 24 hours the intensity measured from all the devices was similar. At the 24 hour time point, the device induced a hypoxic response equivalent to that seen at 8 hours in the control. The device is under optimization to use in vivo and to artificially induce hypoxia in mammary tumor that will help us to study the effect of hypoxia on tumor metastasis. 
CONCLUSIONS
A MEMS-based device was fabricated using optically transparent, biocompatible materials and customized hydrogel systems. The hydrogel-based reservoir created a growth factor gradient and was able to stimulate and attract cells. The sensing component of the device was fabricated from indium doped tin oxide and gold materials and was tested at different cell densities. The electrode impedance measurement was able to clearly distinguish between different cell densities. The device was also used as dispersant to mimic a hypoxic environment in vitro. New designs of the NANIVID are under development and are being optimized for use as a cell collecting device with a customized hydrogel system and use as a disseminator of specific agent in vivo.
